COO,EOLS Stock Price and Quote

Peers: ALGN SYK JNJ ISRG BSX ZBH MDT BAX HOLX STE

| Held by: VTI VOO VB VO SPY IVV RSP VBR XLV VTV

Index	S&P 500	P/E	32.24	EPS (ttm)	2.03	Insider Own	0.66%	Shs Outstand	198.80M	Perf Week	-4.81%
Market Cap	13.02B	Forward P/E	14.85	EPS next Y	4.41	Insider Trans	1.23%	Shs Float	197.50M	Perf Month	-10.84%
Enterprise Value	15.37B	PEG	3.43	EPS next Q	1.11	Inst Own	102.51%	Short Float	3.33%	Perf Quarter	-6.05%
Income	407.80M	P/S	3.22	EPS this Y	10.90%	Inst Trans	0.98%	Short Ratio	2.40	Perf Half Y	-19.38%
Sales	4.05B	P/B	1.56	EPS next Y	7.79%	ROA	3.33%	Short Interest	6.58M	Perf YTD	-28.77%
Book/sh	42.02	P/C	104.23	EPS next 5Y	9.40%	ROE	5.01%	52W High	112.38 -41.73%	Perf Year	-39.66%
Cash/sh	0.63	P/FCF	31.60	EPS past 3/5Y	-49.03% -3.45%	ROIC	3.78%	52W Low	61.78 6.00%	Perf 3Y	-14.93%
Dividend Est.	0.01 (0.02%)	EV/EBITDA	13.84	Sales past 3/5Y	10.05% 7.98%	Gross Margin	62.03%	Volatility	2.12% 2.68%	Perf 5Y	-17.69%
Dividend TTM	-	EV/Sales	3.80	EPS Y/Y TTM	12.94%	Oper. Margin	18.31%	ATR (14)	2.09	Perf 10Y	73.61%
Dividend Ex-Date	Jul 26, 2023	Quick Ratio	1.24	Sales Y/Y TTM	6.35%	Profit Margin	10.08%	RSI (14)	38.07	Recom	1.78
Dividend Gr. 3/5Y	- -	Current Ratio	2.12	EPS Q/Q	-5.82%	SMA20	-6.22%	Beta	1.02	Target Price	83.29
Payout	0.00%	Debt/Eq	0.30	Sales Q/Q	5.73%	SMA50	-8.41%	Rel Volume	1.08	Prev Close	66.68
Employees	16000	LT Debt/Eq	0.29	Earnings	Aug 27 AMC	SMA200	-19.91%	Avg Volume	2.74M	Price	65.48
IPO	Jan 21, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.23% -0.34%	Trades		Volume	2,923,604	Change	-1.80%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-28-25	Downgrade	Citigroup	Buy → Neutral	$72
Jul-22-25	Upgrade	BNP Paribas Exane	Neutral → Outperform	$92
Jun-17-25	Upgrade	Needham	Hold → Buy	$94
May-30-25	Downgrade	JP Morgan	Overweight → Neutral	$76
Aug-29-24	Reiterated	Piper Sandler	Overweight	$115 → $120
Jul-16-24	Upgrade	Jefferies	Hold → Buy	$107 → $115
Mar-19-24	Upgrade	Redburn Atlantic	Neutral → Buy	$125
Mar-13-24	Upgrade	JP Morgan	Neutral → Overweight	$100 → $120
Feb-06-24	Resumed	KeyBanc Capital Markets	Sector Weight
Oct-30-23	Initiated	BofA Securities	Buy	$380
Oct-05-23	Downgrade	Redburn Atlantic	Overweight → Neutral	$390 → $343
May-30-23	Initiated	Morgan Stanley	Equal-Weight	$410
Dec-22-22	Initiated	Mizuho	Buy	$375
Nov-30-22	Upgrade	Robert W. Baird	Neutral → Outperform	$345 → $375
Oct-12-22	Downgrade	Jefferies	Buy → Hold	$400 → $295
Aug-29-22	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-17-22	Upgrade	Citigroup	Neutral → Buy	$460 → $405
Apr-08-22	Initiated	Needham	Hold
Jan-03-22	Upgrade	Guggenheim	Neutral → Buy
Sep-03-21	Reiterated	Stifel	Buy	$450 → $475

Show Previous Ratings

Sep-15-25 09:40AM	Here's Why The Cooper Companies (COO) is a Strong Value Stock (Zacks)
Sep-09-25 12:02AM	3 Reasons COO is Risky and 1 Stock to Buy Instead (StockStory)
Sep-03-25 01:31AM	5 Insightful Analyst Questions From CooperCompanies's Q2 Earnings Call (StockStory)
Sep-02-25 03:30PM	Why CooperCompanies (COO) Shares Are Falling Today (StockStory)
Sep-01-25 09:15AM	Interpreting The Cooper Companies (COO) International Revenue Trends (Zacks)
11:34PM	Loading…
Aug-31-25 11:34PM	Medical Devices & Supplies - Diversified Stocks Q2 Recap: Benchmarking CooperCompanies (NASDAQ:COO) (StockStory)
Aug-29-25 09:47AM	COO Q3 Earnings Beat, 2025 Sales Outlook Lowered, Stock Down (Zacks)
09:40AM	Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term (Zacks)
Aug-28-25 05:28PM	Why Cooper Companies Stock Sank by 13% Today (Motley Fool) -12.85%
04:25PM	These Stocks Moved the Most Today: Nvidia, Snowflake, Pure Storage, CrowdStrike, Hormel Foods, Cooper, HP, and More (Barrons.com)
04:05PM	Why CooperCompanies (COO) Shares Are Falling Today (StockStory)
11:48AM	Cooper Cos. Is Falling on Earnings. Why Citi Downgraded the Stock. (Barrons.com)
11:30AM	Top Stock Movers Now: Hormel, Best Buy, Snowflake, and More (Investopedia)
11:20AM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
11:12AM	These Stocks Are Moving the Most Today: Nvidia, Snowflake, Pure Storage, CrowdStrike, Hormel Foods, Cooper, HP, and More (Barrons.com)
09:50AM	Loading…
09:50AM	COO Q2 Deep Dive: Margin Pressures and Product Shifts Drive Cautious Outlook (StockStory)
09:39AM	Five Below upgraded, Bill downgraded: Wall Street's top analyst calls (The Fly)
05:46AM	Snowflake shares jump after earnings, and other early market movers (MarketWatch)
05:10AM	These Stocks Are Moving the Most Today: Nvidia, CrowdStrike, Snowflake, Cooper, HP, and More (Barrons.com)
03:06AM	The Cooper Companies Inc (COO) Q3 2025 Earnings Call Highlights: Strong Non-GAAP Earnings ... (GuruFocus.com)
Aug-27-25 06:00PM	Here's What Key Metrics Tell Us About The Cooper Companies (COO) Q3 Earnings (Zacks)
05:25PM	The Cooper Companies (COO) Q3 Earnings Beat Estimates (Zacks)
04:49PM	CooperCompanies's (NASDAQ:COO) Q2 Earnings Results: Revenue In Line With Expectations But Stock Drops 11% (StockStory)
04:15PM	CooperCompanies Announces Third Quarter 2025 Results (GlobeNewswire)
Aug-26-25 06:42PM	Analysts Love These 3 Companies Reporting Earnings This Week (MarketBeat)
11:40AM	COO vs. MMSI: Which Stock Is the Better Value Option? (Zacks)
09:55AM	How Much Upside is Left in The Cooper Companies (COO)? Wall Street Analysts Think 26.47% (Zacks)
08:22AM	Cooper Companies Likely to Beat Q3 Earnings Estimate on Lens Demand (Zacks)
Aug-25-25 11:02PM	CooperCompanies (COO) Q2 Earnings Report Preview: What To Look For (StockStory)
09:51AM	Do Wall Street Analysts Like Cooper Companies Stock? (Barchart)
09:15AM	Loading…
Aug-22-25 09:15AM	The Cooper Companies (COO) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
Aug-20-25 10:00AM	The Cooper Companies (COO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Aug-19-25 08:50AM	Cooper Companies' Innovation Fuels Growth Amid Macro Headwinds (Zacks)
Aug-14-25 05:30PM	Plus Therapeutics (PSTV) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:15PM	CooperCompanies to Participate in the Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-12-25 10:58AM	Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical Services and The Cooper Companies (Zacks)
08:13AM	The Cooper Companies (COO) Traded Down in Q2 Despite Strong Results (Insider Monkey)
Aug-11-25 08:28AM	4 Dental Supplies Stocks Likely to Gain Amid Rising Tariff Risks (Zacks)
Aug-07-25 07:40AM	Becton Dickinson (BDX) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
Aug-06-25 05:25PM	McKesson (MCK) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
Aug-05-25 12:16PM	Can Sustained Product Demand Drive BDX Stock Before Q3 Earnings? (Zacks)
12:00PM	All You Need to Know About The Cooper Companies (COO) Rating Upgrade to Buy (Zacks)
11:40AM	COO or SAUHY: Which Is the Better Value Stock Right Now? (Zacks)
07:36AM	Will GLP-1 Demand Drive MCK's Top Line This Earnings Season? (Zacks)
12:00AM	CooperCompanies (COO): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Jul-31-25 08:50AM	Should You Continue to Hold The Cooper Companies (COO)? (Insider Monkey)
Jul-25-25 07:55AM	What to Expect From Cooper Companies' Q3 2025 Earnings Report (Barchart)
Jul-24-25 04:15PM	CooperCompanies Announces Release Date for Third Quarter 2025 (GlobeNewswire)
Jul-22-25 11:56AM	CooperCompanies (COO) Stock Trades Up, Here Is Why (StockStory)
Jul-14-25 06:20AM	Should Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW) Be on Your Investing Radar? (Zacks)
Jul-02-25 08:21AM	COO Stock Declines Despite Strong Core Growth Amid Fertility Woes (Zacks)
Jul-01-25 01:32AM	The 5 Most Interesting Analyst Questions From CooperCompanies's Q1 Earnings Call (StockStory)
Jun-23-25 11:31PM	Medical Devices & Supplies - Diversified Stocks Q1 Teardown: CooperCompanies (NASDAQ:COO) Vs The Rest (StockStory)
09:32AM	HOLX vs. COO: Which GYN Surgical Stock Is the Better Investment Now? (Zacks)
Jun-19-25 11:20AM	How is Cooper Companies Stock Performance Compared to Other Medical Instruments & Supplies Stocks? (Barchart)
Jun-18-25 09:51AM	Roku upgraded, Sarepta downgraded: Wall Streets top analyst calls (TipRanks)
Jun-07-25 09:47AM	3 Oversold Stocks Flashing Bullish Reversal Signals (MarketBeat)
Jun-05-25 05:37PM	S&P 500 Gains and Losses Today: Tesla Shares Skid as Trump and Musk Tussle Over Budget Bill (Investopedia) +5.58%
Jun-03-25 09:45AM	Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term (Zacks)
Jun-02-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
09:15AM	Understanding The Cooper Companies (COO) Reliance on International Revenue (Zacks)
08:43AM	COO Q2 Earnings Signal Growth and Caution: How to Play the Stock? (Zacks)
May-30-25 08:47PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research) -14.61%
02:13PM	Cooper Stock Sinks as Contact Lens Maker Cuts Full-Year Organic Growth Forecast (Investopedia)
12:41PM	Why CooperCompanies (COO) Stock Is Falling Today (StockStory)
11:59AM	Top Stock Movers Now: Regeneron, Ulta Beauty, Cooper, and More (Investopedia)
11:40AM	XRAY vs. COO: Which Stock Should Value Investors Buy Now? (Zacks)
09:32AM	COO Q2 Earnings Beat, 2025 Sales Outlook Tightened, Stock Down (Zacks)
03:08AM	The Cooper Companies Inc (COO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
May-29-25 09:10PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
06:00PM	The Cooper Companies (COO) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
05:30PM	The Cooper Companies (COO) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
04:51PM	CooperCompanies's (NASDAQ:COO) Q1 Sales Beat Estimates (StockStory)
04:30PM	The Cooper Companies: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	CooperCompanies Announces Second Quarter 2025 Results (GlobeNewswire)
09:29AM	Reasons to Retain The Cooper Companies Stock in Your Portfolio Now (Zacks)
May-28-25 03:03AM	CooperCompanies (COO) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
May-23-25 09:15AM	Insights Into The Cooper Companies (COO) Q2: Wall Street Projections for Key Metrics (Zacks)
May-22-25 09:18AM	Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick (Investing.com)
May-20-25 04:15PM	CooperCompanies' 2024 Sustainability Report Showcases Efforts that Benefit People and the Planet (GlobeNewswire)
07:48AM	Cooper Companies Q2 Earnings Likely to Reflect Seasonal Trends (Zacks)
May-15-25 06:35PM	Zomedica Corp. (ZOMDF) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-14-25 11:40AM	XRAY or COO: Which Is the Better Value Stock Right Now? (Zacks)
07:47AM	The Cooper Companies, Inc. (COO): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying (Insider Monkey)
May-12-25 07:33PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
May-08-25 04:15PM	CooperCompanies to Participate in the William Blair Growth Stock Conference (GlobeNewswire)
07:10AM	Dentsply International (XRAY) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
12:36AM	3 Cash-Producing Stocks Facing Headwinds (StockStory)
May-07-25 05:45PM	Staar Surgical (STAA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-06-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
May-01-25 07:55AM	Cardinal Health (CAH) Beats Q3 Earnings Estimates (Zacks)
Apr-30-25 04:15PM	CooperCompanies Appoints Barbara Carbone to Board of Directors (GlobeNewswire)
Apr-29-25 04:15PM	CooperCompanies Announces Release Date for Second Quarter 2025 (GlobeNewswire)
Apr-21-25 10:40AM	The Wyatt Foundation and The Conceive Fertility Foundation Announce Launch of 2025 IVF Grant Program (PR Newswire)
Apr-17-25 11:17AM	Despite Some Deterioration, Utah Medical Products Is A Solid Play (Seeking Alpha)
Apr-03-25 07:36PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research) -5.63%
05:04AM	CooperCompanies (COO): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
Mar-24-25 07:30PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
Mar-17-25 03:12PM	The Cooper Companies, Inc. (NASDAQ:COO): An Eye-Catching Proposal (Insider Monkey)
Mar-13-25 07:24PM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)

The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
White Albert G III	President & CEO	Sep 05 '25	Buy	68.39	10,000	683,900	226,151	Sep 05 05:10 PM
Warner Gerard H III	President, CooperVision, Inc.	Sep 05 '25	Buy	69.23	1,450	100,384	18,319	Sep 05 04:07 PM
McBride Daniel G	EVP & Chief Operating Officer	Sep 02 '25	Buy	65.04	3,000	195,120	63,120	Sep 02 05:17 PM
Andrews Brian G	EVP, CFO & Treasurer	Sep 02 '25	Buy	65.68	1,525	100,162	22,191	Sep 02 05:16 PM
KOZY WILLIAM A	Director	Apr 01 '25	Option Exercise	0.00	2,857	0	31,149	Apr 03 04:09 PM
WEISS ROBERT S	Director	Apr 01 '25	Option Exercise	0.00	2,993	0	288,945	Apr 03 04:09 PM
Rivas Maria	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	2,721	Apr 03 04:08 PM
MADDEN TERESA S	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	12,357	Apr 03 04:08 PM
Lucchese Cynthia L	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	7,661	Apr 03 04:07 PM
Kurzius Lawrence Erik	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	3,777	Apr 03 04:07 PM
Jay Colleen	Director	Apr 01 '25	Option Exercise	0.00	2,721	0	29,521	Apr 03 04:06 PM
Ricupati Agostino	SVP & CAO	Apr 01 '25	Option Exercise	0.00	2,076	0	9,044	Apr 03 04:06 PM
McBride Daniel G	EVP & Chief Operating Officer	Feb 01 '25	Option Exercise	0.00	22,777	0	71,687	Feb 04 04:25 PM
White Albert G III	President & CEO	Feb 01 '25	Option Exercise	0.00	84,264	0	258,941	Feb 04 04:25 PM
Andrews Brian G	EVP, CFO & Treasurer	Feb 01 '25	Option Exercise	0.00	16,850	0	23,464	Feb 04 04:24 PM
Sheffield Holly R	President, CSI	Feb 01 '25	Option Exercise	0.00	17,309	0	45,843	Feb 04 04:24 PM
White Albert G III	President & CEO	Jan 08 '25	Option Exercise	0.00	18,340	0	183,613	Jan 10 04:12 PM
Warner Gerard H III	President, CooperVision, Inc.	Jan 08 '25	Option Exercise	0.00	13,328	0	23,763	Jan 10 04:12 PM
Sheffield Holly R	President, CSI	Jan 08 '25	Option Exercise	0.00	4,900	0	30,898	Jan 10 04:11 PM
Ricupati Agostino	SVP & CAO	Jan 08 '25	Option Exercise	0.00	4,472	0	9,328	Jan 10 04:11 PM
McBride Daniel G	EVP & Chief Operating Officer	Jan 08 '25	Option Exercise	0.00	8,728	0	53,424	Jan 10 04:11 PM
Andrews Brian G	EVP, CFO & Treasurer	Jan 08 '25	Option Exercise	0.00	6,420	0	13,034	Jan 10 04:10 PM
Khadder Nicholas	VP, General Counsel & Corp Sec	Jan 08 '25	Option Exercise	0.00	3,492	0	4,369	Jan 10 04:10 PM
White Albert G III	President & CEO	Sep 19 '24	Option Exercise	43.83	114,992	5,040,099	280,265	Sep 20 05:51 PM
White Albert G III	President & CEO	Sep 19 '24	Sale	110.53	114,992	12,710,041	165,273	Sep 20 05:51 PM
Albert G. White III	Officer	Sep 19 '24	Proposed Sale	110.53	114,992	12,709,660		Sep 19 03:53 PM

Peers: ABBV LLY PFE AMGN BMY RVNC MRK TEVA PRGO PRPH

| Held by: VTI IWM VXF IWO VTWO SCHA VHT XPH IHE IWC

Index	RUT	P/E	-	EPS (ttm)	-0.97	Insider Own	21.44%	Shs Outstand	64.64M	Perf Week	-12.88%
Market Cap	428.86M	Forward P/E	23.31	EPS next Y	0.28	Insider Trans	-1.84%	Shs Float	50.82M	Perf Month	3.59%
Enterprise Value	522.03M	PEG	-	EPS next Q	-0.15	Inst Own	86.59%	Short Float	22.89%	Perf Quarter	-33.23%
Income	-61.99M	P/S	1.54	EPS this Y	-85.69%	Inst Trans	9.27%	Short Ratio	8.71	Perf Half Y	-49.77%
Sales	277.94M	P/B	-	EPS next Y	160.99%	ROA	-26.80%	Short Interest	11.63M	Perf YTD	-39.95%
Book/sh	-0.29	P/C	6.95	EPS next 5Y	-	ROE	-18729.61%	52W High	17.82 -62.79%	Perf Year	-56.58%
Cash/sh	0.95	P/FCF	-	EPS past 3/5Y	4.74% 23.91%	ROIC	-46.31%	52W Low	5.71 16.11%	Perf 3Y	-36.62%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	38.76% 50.12%	Gross Margin	65.11%	Volatility	5.40% 4.97%	Perf 5Y	70.44%
Dividend TTM	-	EV/Sales	1.88	EPS Y/Y TTM	-7.23%	Oper. Margin	-15.79%	ATR (14)	0.40	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.86	Sales Y/Y TTM	17.15%	Profit Margin	-22.31%	RSI (14)	34.55	Recom	1.29
Dividend Gr. 3/5Y	- -	Current Ratio	2.27	EPS Q/Q	-46.74%	SMA20	-10.22%	Beta	1.07	Target Price	18.83
Payout	-	Debt/Eq	-	Sales Q/Q	3.70%	SMA50	-17.69%	Rel Volume	1.16	Prev Close	7.19
Employees	332	LT Debt/Eq	-	Earnings	Aug 05 AMC	SMA200	-38.30%	Avg Volume	1.34M	Price	6.63
IPO	Feb 08, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-150.20% -15.42%	Trades		Volume	1,540,787	Change	-7.79%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-06-25	Downgrade	Needham	Buy → Hold
Apr-17-25	Initiated	BTIG Research	Buy	$21
Jan-29-24	Upgrade	Barclays	Equal Weight → Overweight	$10 → $16
Jun-23-22	Initiated	Needham	Buy	$18
May-12-22	Upgrade	Barclays	Underweight → Equal Weight	$8 → $10
Jan-20-22	Upgrade	Truist	Hold → Buy	$11
May-06-21	Upgrade	Mizuho	Neutral → Buy	$15
Apr-08-21	Reiterated	H.C. Wainwright	Buy	$20 → $22
Feb-24-21	Downgrade	Truist	Buy → Hold	$12
Jul-07-20	Downgrade	Mizuho	Buy → Neutral	$8 → $3
Feb-06-20	Resumed	Mizuho	Buy
Nov-26-19	Initiated	SVB Leerink	Outperform	$25
Sep-05-19	Resumed	Mizuho	Buy	$30
Jun-28-19	Initiated	Wells Fargo	Market Perform	$16
Jun-11-19	Initiated	Barclays	Underweight	$13
Mar-20-19	Initiated	SunTrust	Buy	$30
Feb-14-19	Initiated	H.C. Wainwright	Buy	$37
Jan-29-19	Initiated	Stifel	Buy	$27

Show Previous Ratings

Sep-12-25 05:30PM	Evolus Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -7.79%
Sep-08-25 08:30AM	Evolus Announces the Appointment of Tatjana Mitchell as Chief Financial Officer (Business Wire)
Aug-25-25 08:00AM	Evolus Announces Positive Data From Pivotal Trial for Evolysse Sculpt Injectable Hyaluronic Acid Gel Product at 2025 Cosmetic Bootcamp (Business Wire)
Aug-20-25 08:00AM	Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for Evolysse Sculpt Injectable Hyaluronic Acid Gel Product (Business Wire)
Aug-08-25 04:05PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
06:30PM	Loading…
Aug-05-25 06:30PM	Evolus, Inc. (EOLS) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -28.51%
04:05PM	Evolus Reports Second Quarter 2025 Financial Results and Provides Business Updates (Business Wire)
Jul-31-25 10:00AM	Analysts Estimate Haemonetics (HAE) to Report a Decline in Earnings: What to Look Out for (Zacks)
08:05AM	Evolus Announces Publication of Independent Study in JAMA Dermatology Demonstrating Jeuveau as a Top Performer Among Leading Neurotoxins (Business Wire)
Jul-29-25 10:00AM	Earnings Preview: Evolus, Inc. (EOLS) Q2 Earnings Expected to Decline (Zacks)
Jul-22-25 08:05AM	Evolus to Report Second Quarter Financial Results on August 5, 2025 (Business Wire)
Jul-11-25 04:05PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jul-09-25 08:00AM	Evolus Expands Global Footprint with Introduction of Nuceiva (botulinum toxin type A) in France (Business Wire)
Jun-13-25 04:05PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jun-10-25 08:00AM	Evolysse Recognized in 2025 Shape Skin Awards (Business Wire)
04:15PM	Loading…
May-27-25 04:15PM	Evolus Announces Departure of its Chief Financial Officer (Business Wire) -5.20%
May-22-25 08:00AM	Evolus Announces Publication of U.S. Pivotal Study for Evolysse Form and Evolysse Smooth Injectable Hyaluronic Acid Gels (Business Wire)
May-16-25 04:05PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-13-25 09:51AM	Evolus, Inc. (EOLS): A Bull Case Theory (Insider Monkey)
May-08-25 09:47AM	Q1 2025 Evolus Inc Earnings Call (Thomson Reuters StreetEvents) -14.20%
03:28AM	Evolus Inc (EOLS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges (GuruFocus.com)
May-07-25 07:14PM	Evolus projects $345M-$355M revenue for 2025 with new product launches (Seeking Alpha)
07:13PM	Evolus, Inc. (EOLS) Q1 2025 Earnings Call Transcript (Seeking Alpha)
06:55PM	Evolus, Inc. (EOLS) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Evolus Reports First Quarter 2025 Results (Business Wire)
May-05-25 04:05PM	Evolus Strengthens Balance Sheet with Refinancing; Reducing Cost of Capital and Expanding Financial Flexibility (Business Wire)
May-01-25 07:30AM	SNDL Inc. (SNDL) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
Apr-30-25 10:01AM	Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know (Zacks)
Apr-23-25 08:00AM	Evolus to Report First Quarter Financial Results on May 7, 2025 (Business Wire) +7.36%
Apr-22-25 07:10PM	Evolus: Two-Product Aesthetics Company With A Competitive Edge (Seeking Alpha)
04:05PM	Loading…
Apr-18-25 04:05PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-16-25 08:00AM	Evolus Announces Commercial Launch of Evolysse (Business Wire)
Apr-15-25 08:00AM	Evolus Launches "Drop the F Word" Campaign in Advance of the Commercial Launch of Evolysse Injectable Hyaluronic Acid Gels (Business Wire)
Mar-25-25 08:00AM	Evolus to Participate in The Needham 24th Annual Virtual Healthcare Conference (Business Wire)
Mar-21-25 04:05PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-10-25 04:53PM	Mixue Group's Splashy Debut, Kroger's Change, Stuffed Crust Pizza, and Med Spas (Motley Fool) -6.63%
Mar-05-25 07:13AM	Q4 2024 Evolus Inc Earnings Call (Thomson Reuters StreetEvents)
02:09AM	Evolus Inc (EOLS) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... (GuruFocus.com)
Mar-04-25 05:25PM	Evolus, Inc. (EOLS) Q4 Earnings and Revenues Lag Estimates (Zacks)
04:05PM	Evolus Reports Record Fourth Quarter and Full-Year 2024 Financial Results; Reaffirms 2025 Guidance (Business Wire)
Mar-02-25 06:08PM	Is Evolus, Inc. (EOLS) the Best Small Cap Pharma Stock to Buy Now? (Insider Monkey)
Feb-27-25 08:00AM	Evolus to Participate in Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences (Business Wire)
Feb-20-25 08:00AM	Evolus to Participate in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit (Business Wire)
Feb-18-25 08:00AM	Evolus to Report Fourth Quarter and Year End 2024 Results on March 4, 2025 (Business Wire)
Feb-14-25 08:53AM	Evolus (EOLS) Moves 5.5% Higher: Will This Strength Last? (Zacks)
Feb-13-25 01:30PM	Evolus Announces FDA Approval of Evolysse Form and Evolysse Smooth Injectable Hyaluronic Acid Gels (Business Wire) +5.47%
Feb-07-25 07:09PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jan-22-25 07:46AM	Evolus (EOLS) Surges 28.3%: Is This an Indication of Further Gains? (Zacks)
Jan-21-25 04:04PM	Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere Here's Why (Investor's Business Daily) +28.26%
08:00AM	Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Net Revenue, Achieving Record Results at the Top of the Companys Guidance (Business Wire)
Jan-17-25 04:05PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Dec-13-24 04:05PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Nov-18-24 09:55AM	Here's Why Evolus (EOLS) Could be Great Choice for a Bottom Fisher (Zacks)
Nov-14-24 09:35AM	Down -29.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Evolus (EOLS) (Zacks)
Nov-07-24 06:00AM	Evolus Inc (EOLS) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Market Challenges (GuruFocus.com) -14.99%
Nov-06-24 06:25PM	Evolus, Inc. (EOLS) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:05PM	Evolus Reports Third Quarter 2024 Results (Business Wire)
Nov-01-24 08:00AM	Evolus to Participate in Stifel 2024 Healthcare Conference (Business Wire)
Oct-31-24 02:02PM	Evolus Announces EU Approval of Estyme Injectable Hyaluronic Acid Gels Under New Medical Device Regulation (Business Wire)
Oct-30-24 10:01AM	Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know (Zacks)
Oct-29-24 08:00AM	Evolus Rewards Patient Loyalty Program Surpasses 1 Million Enrolled Consumers (Business Wire)
Oct-23-24 08:00AM	Evolus to Report Third Quarter Financial Results on November 6, 2024 (Business Wire)
Oct-11-24 10:53PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Oct-09-24 03:36PM	Evolus Inc (EOLS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements (GuruFocus.com)
Sep-27-24 09:00PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-06-24 08:00AM	Evolus to Ring the Nasdaq Stock Market Closing Bell on Friday, September 13, 2024 (Business Wire)
Aug-09-24 04:30PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
07:39AM	Evolus, Inc. (EOLS): Is It One of Caligan Partners Top Holdings Now? (Insider Monkey)
Aug-01-24 04:00PM	Evolus, A Medical Aesthetics Player, Becomes Profitable Two Quarters Early (Investor's Business Daily) +13.04%
Jul-31-24 09:56PM	EOLS Stock Earnings: Evolus Misses EPS, Beats Revenue for Q2 2024 (InvestorPlace)
06:45PM	Evolus, Inc. (EOLS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Evolus Reports Second Quarter 2024 Results and Raises Full Year Revenue Guidance (Business Wire)
08:00AM	Evolus to Hold Investor Day on September 12, 2024 (Business Wire)
Jul-30-24 08:00AM	Evolus Expands Global Footprint with Introduction of Nuceiva (botulinum toxin type A) in Australia (Business Wire)
Jul-25-24 08:00AM	Evolus to Participate in the Canaccord Genuity 44th Annual Growth Conference (Business Wire)
Jul-23-24 07:03AM	Evoluss frown line treatment Jeuveau could threaten Botox revenues (Pharmaceutical Technology)
Jul-17-24 08:00AM	Evolus to Report Second Quarter Financial Results on July 31, 2024 (Business Wire)
Jul-01-24 08:00AM	Evolus Announces Appointment of Albert G. White III to Board of Directors (Business Wire)
Jun-24-24 08:00AM	Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for First Two Evolysse Dermal Filler Products (Business Wire)
Jun-12-24 08:00AM	Evolus Broadens International Presence with Launch of Nuceiva (botulinum toxin type A) in Spain (Business Wire)
Jun-07-24 05:00PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -5.73%
May-28-24 01:00AM	The Evolution of Medical Aesthetics and Its Growing Foothold in the Beauty Space (WWD)
May-21-24 10:57AM	Evolus (EOLS) Releases Favorable Dermal Fillers Study Data (Zacks)
May-20-24 08:30AM	Evolus Announces Positive Data from Pivotal Trial for First Two Evolysse Dermal Filler Products at 2024 SCALE Meeting (Business Wire)
May-16-24 02:54AM	Director David Gill Sells 10,361 Shares of Evolus Inc (EOLS) (GuruFocus.com)
02:54AM	Director Vikram Malik Sells 28,000 Shares of Evolus Inc (EOLS) (GuruFocus.com)
May-15-24 08:30AM	Evolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau at the Women's Wear Daily Beauty CEO Summit (Business Wire)
May-10-24 06:55PM	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
09:10AM	Evolus Sandra Beaver Named Orange County Business Journals Public Company CFO of the Year (Business Wire)
May-08-24 11:09AM	Evolus, Inc. (NASDAQ:EOLS) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:24AM	Q1 2024 Evolus Inc Earnings Call (Thomson Reuters StreetEvents)
03:53AM	Evolus Inc (EOLS) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth and Strategic ... (GuruFocus.com)
May-07-24 08:58PM	EOLS Stock Earnings: Evolus Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:35PM	Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:46PM	Evolus Inc (EOLS) Q1 2024 Earnings: Surpasses Revenue Estimates with Significant Growth (GuruFocus.com)
04:05PM	Evolus Reports First Quarter 2024 Results and Provides Business Update (Business Wire)
May-02-24 07:37AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
Apr-23-24 04:30PM	Evolus to Report First Quarter Financial Results on May 7, 2024 (Business Wire)
Apr-21-24 10:39AM	11 Best Low Price Pharma Stocks To Invest In (Insider Monkey)
Apr-17-24 04:05PM	Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for Extra-Strength 40U Formulation of Jeuveau (Business Wire)

Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Yamagishi-Dressler Tomoko	Chief Marketing Officer	Aug 22 '25	Sale	7.51	5,722	42,972	89,949	Aug 26 06:26 PM
Stewart Brady	Director	Aug 15 '25	Buy	6.82	30,000	204,486	88,629	Aug 18 04:28 PM
MOATAZEDI DAVID	See Remarks	Jun 13 '25	Sale	10.05	111,323	1,119,141	381,509	Jun 16 04:42 PM
MOATAZEDI DAVID	See Remarks	Jun 16 '25	Sale	9.89	16,582	164,054	364,927	Jun 16 04:42 PM
DAVID MOATAZEDI	Officer	Jun 16 '25	Proposed Sale	9.89	16,582	164,052		Jun 16 04:03 PM
DAVID MOATAZEDI	Officer	Jun 13 '25	Proposed Sale	10.05	111,323	1,119,141		Jun 13 05:23 PM
White Albert G III	Director	Jun 09 '25	Buy	9.45	20,000	189,000	50,378	Jun 10 05:04 PM
Avelar Rui	See Remarks	May 12 '25	Sale	9.87	3,385	33,397	359,082	May 14 07:27 PM
Beaver Sandra	Chief Financial Officer	May 13 '25	Sale	10.02	6,494	65,070	167,089	May 14 07:27 PM
MOATAZEDI DAVID	See Remarks	May 12 '25	Sale	9.87	15,787	155,756	492,832	May 14 07:27 PM
MOATAZEDI DAVID	See Remarks	Mar 27 '25	Sale	12.40	6,251	77,512	508,619	Mar 28 06:59 PM
Avelar Rui	See Remarks	Mar 18 '25	Sale	13.26	27,904	369,868	362,467	Mar 20 06:27 PM
Beaver Sandra	Chief Financial Officer	Mar 18 '25	Sale	13.26	8,996	119,243	173,583	Mar 20 06:27 PM
Yamagishi-Dressler Tomoko	Chief Marketing Officer	Mar 18 '25	Sale	13.26	4,536	60,125	95,671	Mar 20 06:27 PM
MOATAZEDI DAVID	See Remarks	Mar 18 '25	Sale	13.26	103,376	1,370,249	514,870	Mar 20 06:27 PM
Parschauer Karah Herdman	Director	Mar 12 '25	Sale	12.99	12,888	167,465	32,183	Mar 14 05:59 PM
Parschauer Karah Herdman	Director	Mar 12 '25	Proposed Sale	12.99	12,888	167,465		Mar 12 05:55 PM
Avelar Rui	See Remarks	Dec 23 '24	Sale	10.85	2,252	24,438	366,595	Dec 26 05:28 PM
Beaver Sandra	Chief Financial Officer	Dec 23 '24	Sale	10.85	1,586	17,211	146,916	Dec 26 05:28 PM
MOATAZEDI DAVID	See Remarks	Dec 23 '24	Sale	10.85	10,502	113,967	522,847	Dec 26 05:28 PM

COO

Cooper Companies, Inc

EOLS

Evolus Inc

Upgrade your FINVIZ experience